Literature DB >> 7263851

Determination of brucella immunoglobulin G agglutinating antibody titer with dithiothreitol.

G C Klein, K A Behan.   

Abstract

The routine brucella agglutination test measures both immunoglobulin M (IgM) and IgG brucella antibody titers; however, only an elevated IgG titer is significant for differentiating active from inactive disease in patients with symptoms lasting 3 or more weeks. The IgG antibody titer can be determined by treating the serum wih 2-mercaptoethanol to inactivate the IgM brucella antibodies while leaving the IgG brucella antibodies intact. Dithiothreitol, which also inactivates IgM, was compared with 2-mercaptoethanol for the determination of IgG brucella agglutination titers. The dithiothreitol and 2-mercaptoethanol test results agreed within +/- 1 dilution step in 103 of 105 serum specimens tested, for a 98.1% rate of agreement. The results indicate that dithiothreitol can be used in place of 2-mercaptoethanol for determining IgG brucella agglutination titers. Dithiothreitol does not have the offensive odor or the irritant properties of 2-mercaptoethanol.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263851      PMCID: PMC271896          DOI: 10.1128/jcm.14.1.24-25.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  SIGNIFICANCE OF 7S AND MACROGLOBULIN BRUCELLA AGGLUTININS IN HUMAN BRUCELLOSIS.

Authors:  J L REDDIN; R K ANDERSON; R JENNESS; W W SPINK
Journal:  N Engl J Med       Date:  1965-06-17       Impact factor: 91.245

2.  Dissociation of human serum macroglobulins.

Authors:  H F DEUTSCH; J I MORTON
Journal:  Science       Date:  1957-03-29       Impact factor: 47.728

3.  Antibodies in human brucellosis.

Authors:  J D Coghlan; D M Weir
Journal:  Br Med J       Date:  1967-04-29

4.  Production of Fc fragments of IgM.

Authors:  V Yakulis; J Schmale; N Costea
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

5.  Safranin O-stained antigen microagglutination test for detection of brucella antibodies.

Authors:  S L Brown; G C Klein; F T McKinney; W L Jones
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

6.  Techniques and interpretations in the serological diagnosis of brucellosis in man.

Authors:  W R Kerr; W J McCaughey; J D Coghlan; D J Payne; R A Quaife; L Robertson; I D Farrell
Journal:  J Med Microbiol       Date:  1968-11       Impact factor: 2.472

7.  2-mercaptoethanol Brucella agglutination test: usefulness for predicting recovery from brucellosis.

Authors:  T M Buchanan; L C Faber
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

  7 in total
  9 in total

1.  Buffered plate antigen test as a screening test for diagnosis of human brucellosis.

Authors:  N E Lucero; J E Bolpe
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

2.  Detection of antibodies to Afipia species by the microagglutination test.

Authors:  H E Müller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

3.  Comparison of the 2-mercaptoethanol and dithiothreitol tests for determining Brucella immunoglobulin G agglutinating antibody in bovine serum.

Authors:  K J McMahon
Journal:  Can J Comp Med       Date:  1983-07

4.  Comparison of an agar-gel immunodiffusion test with other serological methods for differentiating Brucella infected from vaccinated cattle.

Authors:  K J McMahon
Journal:  Can J Comp Med       Date:  1983-01

Review 5.  Laboratory Diagnosis of Human Brucellosis.

Authors:  Pablo Yagupsky; Pilar Morata; Juan D Colmenero
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

6.  Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production.

Authors:  V Weynants; J Godfroid; B Limbourg; C Saegerman; J J Letesson
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

7.  Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings.

Authors:  G F Araj; A R Lulu; M Y Mustafa; M I Khateeb
Journal:  J Hyg (Lond)       Date:  1986-12

8.  Genome-Wide Identification of Virulence Genes in Erysipelothrix rhusiopathiae: Use of a Mutant Deficient in a tagF Homolog as a Safe Oral Vaccine against Swine Erysipelas.

Authors:  Yoshihiro Shimoji; Yohsuke Ogawa; Manae Tsukio; Kazumasa Shiraiwa; Sayaka Nishikawa; Masahiro Eguchi
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

9.  Reduction of Brucella species and Francisella tularensis cross-reacting agglutinins by dithiothreitol.

Authors:  K A Behan; G C Klein
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.